SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: recommendations from the French society for Immuno-Therapy of Cancer (FITC)
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Since December 2019, the emergence of the severe acute respiratory syndrome (SARS)- coronavirus (CoV)-2, responsible for COVID-19 and its worldwide spread led to devastating medical, economic and social consequences. Recently approved anti-SARS-CoV-2 vaccines (SC2V) offer a new hope to end this crisis.
European Journal of Cancer , éditorial en libre accès, 2020